L519 (Carbidopa and Levodopa Extended-Release 25 mg / 100 mg)
Pill with imprint L519 is Purple, Elliptical / Oval and has been identified as Carbidopa and Levodopa Extended-Release 25 mg / 100 mg. It is supplied by Alembic Pharmaceuticals Inc..
Carbidopa/levodopa is used in the treatment of parkinson's disease; neuroleptic malignant syndrome; gtp-ch deficiency and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Carbidopa/levodopa 25 mg / 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for L519
Carbidopa and Levodopa Extended-Release
- Imprint
- L519
- Strength
- 25 mg / 100 mg
- Color
- Purple
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Dopaminergic antiparkinsonism agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Alembic Pharmaceuticals Inc.
- National Drug Code (NDC)
- 62332-0332
Related Images for "L519"
More about carbidopa / levodopa
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- 76 Reviews
- Drug class: dopaminergic antiparkinsonism agents
Consumer resources
- Patient Information
- Carbidopa and levodopa enteral
- Carbidopa and levodopa (Advanced Reading)
- Carbidopa and Levodopa Extended-Release Tablets
- Carbidopa and Levodopa Orally Disintegrating Tablets
- ... +3 more
- Other brands
- Sinemet, Rytary, Sinemet CR, Duopa, Parcopa
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.